SF News Global Supplement News Engine
Trends

Protein Sourcing Shifts: Diversification and Functionality Drive Formulations Beyond Quantity

Supplement manufacturers must pivot from 'protein quantity' to 'protein quality' and functional attributes. Hybrid, plant-based, and fermentation-derived proteins are critical for mitigating cost volatility and meeting evolving consumer demands.

AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →

Also the Cargill salt flats, former salt flats now returning to wetlands, Coyote Point park at the North East end of the bridge (top), and Facebook World Headquarters, in the curve

Protein innovation is transitioning from a 'gram race' to a focus on diverse sources, quality, and functionality, impacting ingredient sourcing and product development for supplement manufacturers. Historically, the market emphasised single-source solutions, but now a wider mix of dairy, plant, fungal, and yeast proteins, alongside precision fermentation derivatives, are gaining prominence. This shift is driven by sustained consumer interest in protein, with Innova Market Insights reporting a 6% average annual growth in protein-containing food and beverage launches between April 2021 and March 2026. However, consumers are increasingly scrutinising quality, taste, processing, price, and health benefits, demanding more than just high protein content.

Formulators are now prioritising amino acid profiles, digestibility, satiety, and targeted benefits like muscle support and healthy ageing, according to Food Ingredients First. Cargill's Aysegul Ozcan confirms that no single protein source is expected to dominate, aligning with Innova data showing 54% of US and Canadian consumers actively adding more protein to their diets, with quality being as important as quantity. This re-evaluation extends to hybrid products, combining dairy and plant proteins or blending various plant proteins to optimise taste, texture, nutrition, and cost. For example, ADM's expansion in soy and pea-based ingredients indicates a move towards broader application in drinks, bakery, and specialised nutrition.

Cost pressures are a significant driver for this diversification. Persistent high whey prices and supply constraints, as highlighted by Nura's director Philip Coggins, are accelerating the search for alternatives. Clear pea and rice protein blends, yeast proteins, and collagen-whey combinations are being explored, enabling protein fortification in challenging formats like clear beverages. The World Business Council for Sustainable Development's 2026 Business Breakthrough Barometer also shows leading businesses investing in new crops and processing technologies to re-position protein portfolios and manage supply risk.

Fermentation-based proteins are also moving into the mainstream. The Protein Brewery's Fermotein, a mycelium-based protein, secured EU novel food approval in June 2026, signalling the viability of such sources. Precision fermentation, exemplified by ADM's partnership with The Every Company for OvoPro (an egg white protein designed for binding, foaming, and gelling), offers specific functional attributes beyond basic nutrition. These developments indicate that the future of protein will be highly flexible, focusing on the optimal protein or blend for specific product applications, price points, and health claims, rather than a singular 'winning' source.

What this means for United Kingdom

UK supplement manufacturers must proactively diversify their protein supply chains to mitigate raw material price volatility and ensure continuity. Reformulation windows should focus on developing hybrid protein solutions, leveraging fava bean, lentil, and sunflower proteins to enhance sustainability credentials and improve cost-efficiency against traditional whey. With 61% of European Gen Z consumers increasing protein intake, brands must innovate beyond 'more protein' to offer specific functional benefits, taste, and desirable textures. Compliance teams should monitor novel food approvals, particularly for EU-approved fermentation-derived proteins like Fermotein, which could open new functional ingredient opportunities in the UK post-Brexit under retained EU law or future domestic regulatory frameworks, potentially by Q4 2026.

Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.